Article ID Journal Published Year Pages File Type
5627064 Clinical Neurology and Neurosurgery 2017 5 Pages PDF
Abstract
The preadmission beta-blocker cannot decrease the incidence of mortality, cardiac dysfunction, cerebral vasospasm in patients with aSAH. A further research of the usefulness of preadmission beta-blocker in patients with aSAH will be needed.
Keywords
Related Topics
Life Sciences Neuroscience Neurology
Preview
Effects of preadmission beta-blockers on neurogenic stunned myocardium after aneurysmal subarachnoid hemorrhage: A meta- analysis
Authors
, , , , , ,